Tag: AVF

Flex Vessel Prep

VentureMed completes enrolment of Flex Vessel Prep system randomised controlled trial...

VentureMed Group recently announced that it has completed enrolment of a randomised controlled trial (RCT) titled 'Flex Vessel Prep prior to PTA for the...

Pharmacological approaches to reducing arteriovenous fistula failure rates

Sanjay Misra (Rochester, USA) discusses the need for pharmacological approaches that can improve successful, long-term outcomes with arteriovenous fistulas (AVFs) and outlines a handful...

IN.PACT AV DCB “first and only” to show sustained and superior...

Medtronic has announced new randomised controlled data demonstrating the sustained and superior performance of the IN.PACT AV drug-coated balloon (DCB) compared to percutaneous transluminal...
alio smartpatch

The Alio SmartPatch™: Optimising dialysis patient monitoring with a wearable, non-invasive...

This advertorial is sponsored by Alio Medical Owing to the various risk factors and potential complications faced by kidney disease patients undergoing dialysis treatment, new...
avg haemodialysis access

A raft of new directions for vascular access grafts

A departure from the “extreme mantra” of Fistula First unlocks the door to a new, dynamic vision that could swing the pendulum back to...

Largest real-world experience to date with VasQ device indicates long-term benefits...

The VasQ external support device (Laminate Medical) has demonstrated long-term benefits for radiocephalic (forearm) arteriovenous fistula (AVF) creation in a retrospective analysis of 150...

Humacyte announces publication of positive long-term follow-up data from phase 2...

Humacyte today announced that five-year data from a phase 2 clinical trial of patients receiving the investigational Human Acellular Vessel (HAV) for arteriovenous (AV)...
4fr wavelinq system

Largest patient series to date reinforces 4Fr WavelinQ system’s potential in...

A multicentre experience with the 4 French (4Fr) WavelinQ endoAVF system (BD) has found that the device is safe and effective, bolstering existing evidence...

Far infrared treatment of arteriovenous fistulas presents no acute haemodynamic changes

Far infrared radiation (FIR) has demonstrated no haemodynamic changes in the arteriovenous fistulas (AVFs) of haemodialysis patients, despite prior contradicting research. This is the...

Fistula trials among key areas set to benefit from MedAlliance acquiring...

Arteriovenous fistula (AVF) access is one of the key areas that is set to receive a boost following MedAlliance’s acquisition of its partner MDK...

IMPRESSION trial assessing MagicTouch AVF passes 50% enrolment

Concept Medical has shared the latest update from its IMPRESSION (Sirolimus-coated balloon angioplasty versus plain balloon angioplasty in the treatment of dialysis access dysfunction)...

Dialysis tech firm Pathfinder Medical secures £8.5 million

Pathfinder Medical, which has developed a proprietary technology to guide and accurately align catheters in endovascular procedures allowing clinicians to make connections across blood...

Experimental gel shows promise in aiding creation and development of arteriovenous...

Researchers from the University of Alabama at Birmingham (UAB; Birmingham, USA) and US firm Endomimetics are working to develop a long-sought-after, effective therapy that...
fistula non maturation

Combination therapies and dynamic AVFs among options that may solve fistula...

Arteriovenous fistulas (AVFs) are widely considered to be the holy grail in dialysis access, providing a more long-term solution than synthetic arteriovenous grafts (AVGs)...

Arrow recalls percutaneous thrombolytic device kits over risk of separation

Arrow International has recalled its Arrow-Trerotola over-the-wire 7Fr percutaneous thrombolytic device (PTD) kits, which are used to remove clots in adult patients who have...

Amplifi™ Vein Dilation System: A novel device under development designed to...

 The Amplifi Vein Dilation System (Artio Medical) is an innovative device designed to dilate arm veins in preparation for arteriovenous fistula (AVF) surgery using...
ellipsys five-year data

Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data

The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...

Cannulation difficulties among biggest hurdles for device-created fistulas

Difficulties in cannulation are currently as pressing as any other challenge facing patients who undergo device-enabled arteriovenous fistula (AVF) creation for dialysis. This was...
wrapsody first study

“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...

Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...

VenoStent embarks on clinical trial to improve success rate of vascular...

VenoStent has announced successful enrolment in its initial feasibility clinical trial. The clinical trial is testing the safety and efficacy of its 3D-printed bioabsorbable...
dialysis

Stable incidence and survival of AVFs seen in long-term study of...

Despite an older dialysis population, the proportion and survival of arteriovenous fistulas (AVFs) in Danish dialysis patients has not changed over a 39-year period....

IN.PACT AV DCB sustained “superior” effectiveness in subgroups with high reintervention...

Several subgroups of patients treated with the IN.PACT AV drug-coated balloon (DCB; Medtronic) for arteriovenous fistulas (AVFs) demonstrated a “statistically significant” higher rate of...
amplifi veith 2021

Results from first-in-human study of Amplifi vein dilation system presented at...

Preliminary clinical results from a first-in-human study assessing the Amplifi vein dilation system (Artio Medical) were presented at this year’s Vascular InterVentional Advances conference (VIVA;...
fist assist devices fa-1

Global FACT trial reports significant superficial arm vein dilation with FA-1...

Fist Assist Devices has just announced completion of the FACT trial, which evaluated the use of an intermittent pneumatic compression device, model FA-1, to...
amplifi vein dilation system

Artio Medical completes enrolment of first-in-human trial investigating Amplifi vein dilation...

Artio Medical announced today it has completed enrolment in its first-in-human study evaluating the Amplifi vein dilation system. In the study, five patients were treated...
oversized balloon angioplasty

Oversized balloon angioplasty technique safe and effective for AV fistula maturation

A retrospective analysis published in the Journal of Vascular Access (JVA) has shown that the oversized balloon angioplasty technique to assist arteriovenous (AV) fistula...

Multidisciplinary UK panel agrees roadmap and optimal interventions for symptomatic AVF...

Multidisciplinary panel of UK experts agrees on roadmap and optimal stepwise application of interventions for symptomatic AVF stenoses in haemodialysis patients. Ounali Jaffer (London,...

Does anaesthetic technique during AV fistula creation influence long-term successful outcomes?

The largest randomised controlled trial comparing long-term surgical outcomes between two different anaesthetic techniques, the ACCESs study, has just launched in the UK, to...
fist assist devices fa-1

Fist Assist device for focal arm massage and increased vein circulation...

Fist Assist Devices has received US Food and Drug Administration (FDA) 510(k) clearance for use of the Fist Assist FA-1 device in the USA...
magictouch avf

Concept Medical provides update on IMPRESSION trial to evaluate MagicTouch AVF

Concept Medical has provided an update on the progress of the IMPRESSION (sirolimus-coated balloon angioplasty versus plain balloon angioplasty in the treatment of dialysis access dysfunction)...

Arteriovenous fistulas contribute to higher survival of haemodialysis patients with COVID-19

A new study, published online in The Journal of Vascular Access (JVA), suggests that arteriovenous fistulas (AVFs) contribute to higher survival of haemodialysis patients...
treating steal syndrome

Treating steal syndrome: Symptoms, flow rate and anastomosis location all key...

When it comes to treating steal syndrome, the extent to which the dialysis patient in question is displaying symptoms—as well as their flow rate...
Robert Jones in the IR suite

Balloon angioplasty in critical time window central to endovascular success for...

Tackling the main culprit, stenosis in the arteriovenous anastomosis and outflow veins, with balloon angioplasty before it is “too late” can boost maturation rates...
xo score scoring sheath platform

XO Score scoring sheath platform gains CE mark to treat PAD...

Transit Scientific has announced CE mark clearance for its XO Score scoring sheath platform, allowing the technology to be used in the treatment of...
high flow av fistulas

High-flow fistulas remain divisive, with uncertainty over reduction and outcomes

Discussions at this year’s Charing Cross (CX) 2021 Digital Edition (19–22 April, online) indicated that high-flow arteriovenous (AV) fistulas remain one of the more...

Vascular Therapies announces clinical results from phase 3 randomised multicentre clinical...

Vascular Therapies recently announced results from its phase 3 clinical trial in which Sirogen showed encouraging arteriovenous fistula (AVF) outcomes in elderly end-stage renal...
george smith ultrasound guidance cannulation

Ultrasound guidance shown to improve cannulation accuracy, particularly in harder-to-needle AV...

A small, randomised trial conducted in a UK dialysis unit has found that ultrasound guidance can improve cannulation accuracy—and this improvement may be most...